Serum osteoprotegerin and receptor activator of nuclear factor-κB ligand (RANKL) concentrations in allogeneic stem cell transplant-recipients: a role in bone loss?

By Kananen K.   Volin L.   Laitinen K.   Ruutu T.   Välimäki M.  

Osteoporosis International, Vol. 17, Iss. 5, 2006-05 ,pp. : 724-730

Springer Publishing Company

Access to resources Recommend Favorite

Preoperative Serum Receptor Activator of Nuclear Factor-κB Ligand/Osteoprotegerin Predict Stabilization of Spontaneously Restored Sinus Rhythm in Persistent Atrial Fibrillation Patients after Mitral Valve Surgery

By  

Cardiology, Vol. 127, Iss. 3, 2014-01 ,pp. : 183-189

Karger

Access to resources Recommend Favorite

Biological variation and reference intervals for circulating osteopontin, osteoprotegerin, total soluble receptor activator of nuclear factor kappa B ligand and high-sensitivity C-reactive protein

By Sennels H. P.   Jacobsen S.   Jensen T.   Hansen M. S.   Østergaard M.   Nielsen H. J.   Sørensen S.  

Scandinavian Journal of Clinical and Laboratory Investigation, Vol. 67, Iss. 8, 2007-01 ,pp. : 821-835

Informa Healthcare

Access to resources Recommend Favorite

Levels of osteoprotegerin (OPG) and receptor activator for nuclear factor kappa B ligand (RANKL) in serum: Are they of any help?

By Wagner Doris  

Wiener Medizinische Wochenschrift, Vol. 160, Iss. 17-18, 2010-09 ,pp. : 452-457

Springer Publishing Company

Access to resources Recommend Favorite

Association between specific periodontal pathogens, Toll‐like receptor‐4, and nuclear factor‐κB expression in placental tissues of pre‐eclamptic women with periodontitis

By  

JOURNAL OF INVESTIGATIVE AND CLINICAL DENTISTRY (ELECTRONIC), Vol. 9, Iss. 1, 2018-02 ,pp. : n/a-n/a

John Wiley & Sons Inc

Access to resources Recommend Favorite